Results 241 to 250 of about 1,913,764 (268)

TAS-102 with or without bevacizumab treatment for patients with metastatic colorectal cancer: a multi-country cost-effectiveness analysis

Youwen Zhu, Kun Liu, Hong Zhu
openalex   +1 more source

Treatment Navigation in Breast Cancer Management: Process Cost Analysis Based on German Case Studies.

Oncol Res Treat
Nachtigall J, Froitzheim AC, Kurte MS, Dengler R, Welslau M, Busch S, Schumacher H, Kron F.   +7 more
europepmc   +1 more source

Cost analysis of integrating depression treatment into chronic care in Malawi: evidence from a cluster randomised controlled trial. [PDF]

BMJ Open
Mwale O, Mpinga K, Rukundo T, Kamwiyo M, Kayira W, Matanje B, Munyaneza F, Ruderman T, Raviola G, Smith S, Okunogbe A, Kachimanga C, McBain RK.   +12 more
europepmc   +1 more source

Hospital costs of different treatment strategies for anastomotic leakage after total mesorectal excision: a multicentre cost analysis. [PDF]

Tech Coloproctol
Nijssen DJ, Wienholts K, Postma MJ, Bemelman WA, Tuynman J, Laméris W, Tanis PJ, Hompes R, IMARI-study group.   +8 more
europepmc   +1 more source

Drivers of hospital costs in ANCA-associated vasculitis patients with long-term follow-up-a real-world cost analysis. [PDF]

Clin Kidney J
van Leeuwen JR, Soltani FH, van den Hout WB, Rabelink TJ, Teng YKO.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work

Ca-A Cancer Journal for Clinicians, 2021
Teresa L Deshields, Ryan D Nipp
exaly  

Time to add screening for financial hardship as a quality measure?

Ca-A Cancer Journal for Clinicians, 2021
Cathy J Bradley, K Robin Yabroff, Ya-Chen Tina Shih   +2 more
exaly